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Since the  classification of hemolytic streptococci into groups  (1)  and  the 
further subdivision of group A,  the chief pathogens for man, into serological 
types (2), there have been certain difficulties in interpreting the results of the 
type  differentiations.  The  demonstration  of  two  type-specific components, 
designated as M  and T  (3), in most strains of group A streptococci has made it 
possible to explain many of these.  A  knowledge of the relationship of these 
two  antigens  in  the  respective types is  therefore important,  particularly  in 
making possible more accurate epidemiological studies of human streptococcal 
infections. 
Group A hemolytic streptococci are generally in the matt phase when iso- 
lated from human infections.  This variant is characterized by the presence 
of the M  antigen,  which is associated with virulence of the organism.  The 
glossy variant, on the other hand, is rarely, if ever, isolated from active infec- 
tions.  It is avirulent for mice, and also appears degraded in that the M  sub- 
stance is absent or present in only minute amounts.  Usually glossy, avirulent 
streptococci and the matt variants both contain the more recently recognized 
type-specific substance, T, which is apparently not related to virulence. 
The M  antigen, protein in nature  (4), can be separated from the bacterial 
cells,  in  the  matt  phase,  and  demonstrated  in  properly prepared  bacterial 
extracts by the precipitin test.  The corresponding antibodies to this substance 
appear to be responsible for the type-specific protection in animals and usually 
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agglutinate  homologous type matt  organisms.  The  T  antigen,  on  the  con- 
trary, has not so far been obtained in cell-free extracts and can be demonstrated 
only by the agglutinin test.  Antibodies to the T  substance may often agglu- 
tinate either the matt or glossy variant, and in some types, are responsible for 
the type-specific agglutination  reaction.  These antibodies apparently do not 
exhibit protective action. 
In  most  of  the  epidemiological  studies  of human  streptococcal  infections 
reported thus far, the slide agglutination technique,  described by Griffith, has 
been employed.  Many investigators using this method of typing have experi- 
enced difficulty with cross reactions, and several (2, 5-11) have noted consistent 
cross  reactions  existing  among  certain  types.  Moreover,  in  our  experience 
typing results with the agglutination method sometimes disagreed with those 
obtained  by the  precipitin  technique.  Many of the  cross reactions,  as  well 
as differences in the results obtained by the two methods for typing, may be 
explained on the varying relationship of the two antigens, M  and T, present in 
many strains of group A hemolytic streptococci (12). 
The present report is concerned with the relationship of the M  and T antigens 
in types 10 and 12.  It is based on precipitin,  agglutination,  and mouse pro- 
tection tests with unabsorbed and reciprocally absorbed antisera obtained from 
rabbits immunized with the matt forms of types 10 and 12.  Since preliminary 
tests indicated that type 10 and type 12 matt strains contained similar, if not 
identical M  antigens, and unrelated type-specific T  antigens, it seemed impor- 
tant  to  investigate  in  more detail  the  specific relationship  existing between 
these  two  types.  In addition  to  the standard  type strains  studied,  twenty- 
three other type 10 or 12 strains collected from various sources were tested to 
ascertain whether the type-specific antigenic composition of these was similar 
to one or the other of the representative type strains. 
Materials  and Methods 
Strain N.Y. 5, recovered by Dochez from a  patient with scarlet fever, was used 
here, as in Griffith's laboratory, as the representative type 10 strain.  It has been 
maintained on culture media and in the dried state (13) in this laboratory for many 
years; and although used as the glossy variant, proved to contain a small amount of M 
protein.  The matt virulent variant, designated as E  14,  was derived from strain 
N.Y. 5, by animal passage. 
Strain S.F. 42, recovered originally  from a patient with scarlet fever, was taken as 
the representative type 12 strain.  It was obtained from Dr. F. Griffith in an avirulent, 
glossy phase and has been maintained in this laboratory on culture media and in the 
dried state.  The matt virulent variant was derived from strain S.F. 42 by mouse 
passage. 
In Table III, the other type 10 and type 12  strains tested are also listed and their 
sources  designated. 
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described.  The antisera were absorbed with streptococci killed  by heating for 30 
minutes at 56°C.  Three parts of undiluted serum were mixed thoroughly with one 
part of packed bacteria and the mixture was incubated at 37°C. for 30 minutes.  The 
serum was then removed after centrifugation at high speed; and merthiolate, one part 
to 10,000 parts of serum, was added.  In certain instances reabsorptions, using four 
to five parts of serum to one part of packed bacteria, were necessary. 
The techniques used in  the precipitin  (15) and agglutinin  (3) tests are described 
elsewhere  Suspensions  for the agglutinin tests were prepared from cultures grown 
in modified  Todd-Hewitt broth (16) at room temperature for 12 to 18 hours.  The 
bacteria were separated from the cultures by centrifugation and resuspended in the 
desired  concentration in  fresh broth. 
The Rockefeller Institute strain of mice, 3 to 4 weeks old, and weighing about 20 
gm., was employed for all protection tests.  One-half cc. of antiserum was injected 
intraperitoneally into each mouse 12  to 18 hours before intraperitoneal inoculation 
with  the  test  culture.  The  latter  consisted  of progressive dilutions,  in  modified 
Todd-Hewitt broth, of blood broth cultures incubated for 12 to 15 hours at 37°C. 
EXPERIMENTAL 
Preliminary tests showed that the type 12 matt variant, obtained by mouse 
passage, could not be differentiated from the type 10 matt strain by the precipi- 
tin test  (M-anti-M reaction): but with properly absorbed antisera,  these two 
types were readily identified by the agglutinin reaction. 
The  results  of the  agglutinin  and  precipitin  tests made with  type  10  and 
type 12 matt antisera are recorded in Table I.  A type 14 matt virulent strain 
and the homologous type 14 antiserum were used as heterologous type controls 
throughout.  No significant cross reactions were observed between the heter- 
ologous control strain and  the representative type 10 and  12  strains or their 
respective matt antisera. 
It is clear from Table I, that M  extracts prepared from the matt variants of 
type 10 and type 12 reacted equally well with the antisera of either type.  The 
results of the agglutinin tests agreed with the results of the precipitin reactions 
as demonstrated by the cross agglutination between the matt variants of types 
10 and 12.  With each type strain, however, in contrast to the precipitin reac- 
tion, the agglutinin test was more marked with its homologous type antiserum 
due  to  the  additional  type-specific T-anti-T  reaction.  The  type  10  glossy 
variant contained a small amount of M protein as demonstrated by the positive 
precipitin tests with both type 10 and 12 matt antisera and the cross agglutina- 
tion  with  type  12  matt antiserum.  The  type  12  glossy strain  on  the  other 
hand contained no demonstrable M  protein by the precipitin test and gave a 
positive agglutinin  reaction only with  the  homologous type antiserum. 
The  ~  reciprocal absorption  experiments recorded  in  Table I  show  that  the 
M  antibodies of both types 10 and 12 antisera were equally well absorbed by 
the matt strains of either type 10  or type 12.  Absorption with the homolo- 92  GROUP  A HEMOLYTIC STREPTOCOCCI.  III 
gous type matt variants removed both M  and T  antibodies as demonstrated by 
the negative precipitin and aggintinin tests for the matt and glossy forms of 
both types.  However,  absorption with the heterologous type  10  or type  12 
matt strain removed only the M  antibodies as shown by the negative precipitin 
TABLE  I 
Redprocal Absorption Experiments, Types 10 and 12 
Agglutinin and Predpitln Re,  ankhS* 
Antiserum  prepared against 
matt variant 
Type 
10 
12 
Strain used for suspensions  and M  extracts 
Typel0matt  {  Type  l0  glossy  I Typel2matt  ITypel2glossy 
Results  of immunological  reactions 
Treatment of antisera 
Not absorbed 
Absorbed  with  type  14  matt 
"  "  "  10  " 
"  "  "  10 glossy 
"  "  "  12 matt 
"  "  "  12 glossy 
Not absorbed 
Absorbed with type 14 matt 
"  "  "  10  ¢¢ 
"  "  "  I0  glossy 
"  "  "  12 matt 
"  "  "  12 glossy 
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+  +  -- 
++++  ++  ++ 
++  ++  ~++~ 
++  ++  +++ 
_  _  +++ 
+  +  +++ 
++  ++  +++ 
Precio 
pitin 
+++ 
++ 
++ 
I-++4 
+++ 
+ 
++ 
A~glu- 
tmln 
+÷+-t 
-i-++-} 
+++ 
+++ 
i+++ 
[  - 
l 
Preci- 
pitln 
For the agglutinin tests, 0.5 cc. amounts of the bacterial suspension were added  to serial 
dilutions of the antiserum.  The final dilutions  of the antiserum ranged  between 1:20 and 
1 : 1280. 
For the precipitin tests, M extracts  undiluted and in dilutions of  1:4  and  1:16  were  set 
up with a constant amount of the antiserum. 
++++  to  --  indicates estimates of the degree of reaction in the agglutinin and precipitin 
tests. 
A type 14 matt strain and its homologous  antiserum were used as a heterologous type con- 
trol for the precipitin and agglutinin tests.  No  significant cross reactions were observed. 
Also normal serum and broth or saline controls were included in every experiment.  These 
controls were invariably negative. 
* For details of technique, see Methods. 
and  cross  agglutination reactions  with  the  matt  variants  and  the  positive 
agglutinin tests with the homologous type matt and glossy forms.  An excep- 
tion to this, probably due to a technical error in failing to absorb the antiserum 
completely, was found when the precipition tests with type 10 M  extract were 
performed  with  the  lots  of  type  10  antisera  absorbed respectively with  the 
type 10 and 12 matt variants.  On the  other hand, absorption of the type 10 
and type  12  antisera with the homologous type glossy strains removed only 0"3C~ 
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the T  antibodies  as demonstrated by the positive  precipitin and agglutlnin 
reactions  with the matt variants of l~oth types 10 and 12  and the negative 
agglutinin tests with the homologous type glossy forms.  Absorption  with the 
heterologous type 10 or 12 glossy strain, however, failed to remove either the 
M or T antibodies as shown by the positive precipitin and agglutinin tests with 
the matt variants of both types and the positive  agglutination reactions with 
the homologous type glossy and matt forms.  Following absorption with the 
type 10 glossy strain the M antibody titer of both type 10 and type 12 antisera 
was reduced because this strain, presumably degraded from the matt form in 
which phase it was originally isolated, still contained some M  substance. 
From the results  of the precipitin and agglutinin tests, the type 10 and 12 
strains appeared to contain serologically identical M  antigens and unrelated 
type-specific  T  antigens.  It  is  now  known that  virulent  strains  elaborate 
relatively large amounts of M substance, and that sera with good type-specific 
protective capacity have high anti-M precipitin  titers.  On  the other hand, 
there is no evidence as yet to indicate that the T  antibody is concerned with 
protection.  A series of experiments  was,  therefore,  performed  to determine 
whether antisera prepared against the matt variants of these two types would 
exhibit  cross protective action. 
In Table II are recorded  the results  of mouse protection tests made with 
unabsorbed and reciprocally  absorbed  type 10 and type 12 antisera prepared 
against the matt variants.  The antisera used in these experiments were from 
the same lots employed in the serological tests svmmarized in Table I; and the 
same type 14 matt virulent strain and its homologous antiserum again were 
used as the heterologous type controls.  It is evident from Table II that the 
types 10 and 12 antisera, both before and after absorption with the heterologous 
type 14  culture, protected equally well when  tested with the matt virulent 
strain of either type.  It is also apparent that cross absorption of these antisera 
with the matt variants was as effective in removing  the protective action as 
was absorption with the homologous matt variant.  The type 10 antiserum, 
after absorption with either the homologous type 10 or type 12 matt strain, 
still showed some protective action when tested with the homologous type 10 
virulent matt culture.  This is in accord with the fact that the M  antibodies 
were not completely removed from this antiserum, as mentioned above, follow- 
ing absorption with either the homologous type 10 matt or type 12 matt strain, 
as is shown by the slightly positive precipitin (M-anti-M) reactions in Table I. 
In contrast to the loss of the protective capacity of the type 10 and type 12 
matt antisera by absorption with either matt variant,  this action was  not 
appreciably affected by absorption with the glossy form of either type.  The 
results of these experiments show that the protective capacity of these antisera 
was parallel with their M antibody contents but could not be correlated with 
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TABLE  IH 
The Serological Identification of Strains Belonging to Types 10 and 12 
Strain 
N.Y. 5 
E  14 
8115 
8186 
10295 
11275 
AWI7B 
AW56 
AW57 
S.F. 42 
T 12 
671 Pata. 
610 Esk. 
10RS14 
R2 
R  29 
R 97 
R 102 
F200C 
C152 
650 Pa. 
686 Bell. 
C 186 
R 63 
815 Chi. 
Wilson 868 
F203B 
Source 
Type 10 representative  strains 
Scarlet fever, Dr. A. R. Dochez, type l0 glossy~ 
N.Y. 5 after animal passage, type 10 matt 
Other type 10 strains 
Scarlet fever, isolated in Rumania, Dr. F. Schwentker 
Dr. Anna Williams 
Type 12 representative strains 
Scarlet fever, Dr. F. Griflith, type 12 glossy 
S.F.  42 after  animal passage, type 12 matt 
Other type 12 strains 
Rheumatic fever  subject,  Dr. A. Kuttner 
"  "  Rockefeller  Institute  Hospital 
Carrier,  U. S. Navy 
Septicemia, Dr. Perrin Long 
Rheumatic fever,  Haverstraw,  New York 
"  "  subject, Dr. A. Kuttner 
"  "  "  "  K. Dodge 
Carrier, U. S. Navy 
Rheumatic fever subject, Dr. A. Kuttner 
Wound infection, Dr. L. Colebrook 
Acute nephritis,  "  B. Seegal 
An•glutinin 
reaction* 
tibody content of sera 
Precipitln 
reaction* 
Antibody 
content 
of  sera 
Type 
12 
anti- 
M 
+ 
+ 
.4- 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-t- indicates positive reaction. 
-  indicates negative reaction. 
Blank  indicates no  test. 
* For details of technique, see Methods and Table I. 
N. Y. 5 strain contained some M  protein, although it was used as the representative type 
10 glossy. 
Analysis of Twenty-Three Additional  Strains 
After  demonstrating  by  agglutinin  and  precipitin  reactions  and  passive  pro- 
tection  tests  that  the  representative  type  10  and  type  12  strains  contained 
serologically  identical  M  antigens,  but  unrelated  type-specific  T  antigens,  it 
became  important  to  determine  whether  other  strains  previously  classified  as 
one  of  these  two  types  contained  the  same  M  and  T  antigenic  components. 96  GROUP  A  HEMOLYTIC  STREPTOCOCCI.  ~I 
Therefore all available strains previously classified into one or the  other of 
these two types were tested.  The results are recorded in Table III.  The anti- 
sera used for the agglutinin reactions were from the same lots of absorbed sera 
employed in the previous experiments.  The precipitin tests were done with 
other lots of absorbed type 10 and 12 antisera, which had been used for routine 
typing. 
On the basis of the T  agglutinogen, seven of the twenty-three strains were 
identified as type 10, and the remaining sixteen as type 12.  With the excep- 
tion  of two,  which  contained small amounts of M  substance,  demonstrable 
only by the precipitin test, all of the type 10 strains were glossy variants.  On 
the other hand, only three of the 16 type 12 strains were glossy forms.  This 
may be correlated with the fact that the majority of the type 12 matt strains 
had been only recently isolated from patients, while most of the type 10 strains 
had been kept in the laboratory for some time.  Four of the strains identified 
as type 12 gave positive precipitin reactions with both type 10 and 12 antisera 
and agglutinated in the type 12 anti-M serum, but failed to give positive agglu- 
tinin reactions with the type 10 anti-M serum.  This apparent discrepancy is 
probably due to the difference in the M  antibody content of the antisera used 
for testing.  The type 10 anti-M serum, used for the agglutinin test, was of 
much lower titer than the other antisera, as indicated above, because some of 
its M antibody was removed by absorption with the type 10 glossy strain which 
contained some type 10-12  M  protein.  The twenty-three additional strains 
tested, therefore, have antigenic compositions similar to one or the other of 
the matt or glossy representative type 10 or type 12 strains. 
DISCUSSION 
In this study a series of experiments is reported showing the antigenic rela- 
tionship of type 10 and type 12 group A hemolytic streptococci.  The repre- 
sentative type 10 strain, N.Y. 5, and type 12 strain, S.F. 42,  employed here, 
were the same as those used by Griffith (2).  Suspensions and M extracts pre- 
pared from both the matt and glossy variants of these two types and a heterolo- 
gous control type 14 matt strain were used in agglutinin and precipitin tests 
with  unabsorbed  and  reciprocally  absorbed  antisera  prepared  against  the 
homologous types 10, 12, and 14 matt cultures.  The results of these experi- 
ments demonstrated that the representative type 10 and type 12 matt strains 
contained  serologically identical  iV[  antigens  but  unrelated  type-specific  T 
antigens.  Passive protection tests done with lots of the same unabsorbed and 
reciprocally absorbed  antisera  employed in  the  agglutination and precipitin 
reactions confirmed the results of the serological tests.  In addition, each of 
twenty-three other strains previously classified as type 10 or type 12, collected 
from various sources, have been shown to have an antigenic composition similar 
to one or the other of the two representative types. 
Although several workers (2, 5-11)  have called attention to cross reactions ROBERT  F.  WATSON  AND  REBECCA  C.  LANCEFIELD  97 
among certain types, we have not encountered any mention previously of dif- 
ficulty in di~erentiating between types 10 and 12 except for a recent report by 
Krumwiede (17).  Griffith who was able to obtain a sharp distinction between 
these two types by the slide agglutination technique, as well as other workers 
who have employed this method, probably used typing antisera of low anti-M 
and high anti-T titer prepared against the glossy variant. 
The recognition now of the two specific antigens, M  and T, present in most 
matt forms of group A streptococci, makes possible a  rational explanation of 
many cross reactions observed by the agglutinin technique among those strains 
containing M or T substances characteristic of more than one type.  With such 
relationships  existing  between  these  two  antigens,  both  of  which  may  be 
responsible for agglutination, it is obvious that anyone employing the agglu- 
tinin method for the typing of streptococci will encounter cross reactions, unless 
methods are used in preparing antisera so that they contain only M  or T  anti- 
bodies.  Moreover,  the  results  of  typing  tests  in  different laboratories  will 
vary, unless antisera with identical antibody content are used by all investi- 
gators.  Most of these difficulties, however, are obviated by employing as a 
typing technique  (18)  the precipitin method which depends entirely on the 
reaction of the single antigen M  with its homologous antibody.  Even when 
two types contain identical M  antigens, as appears to be the case with types 
10 and 12,  the lack of distinction by the precipitin test is of relatively little 
importance from the practical point of view, since the M substance is associated 
with  virulence  and  its  corresponding  antibody  is  related  to  type-specific 
immunity. 
The application of typing streptococci to the management of streptococcal 
infections in the hospital, makes it desirable, therefore, to rely on the M-anti-M 
reaction.  At the present time, it is common practice in hospitals to regard 
streptococcal infections, such as scarlet fever, as a  single disease.  It is now 
known that scarlet fever, as well as erysipelas, puerperal fever, tonsillitis, etc., 
may be  caused by any one of a  number of antigenically unrelated types of 
group A  streptococci (2,  19-21).  Moreover it has recently been shown that 
the great majority of secondary, purulent complications occurring late in scarlet 
fever are due to cross infections with another type of streptococcus from a pa- 
tient in the same ward (22,  23).  It would, therefore, be desirable to put to- 
gether in the same room only those patients whose diseases are caused by the 
same type, as determined by the M-anti-M reaction.  From this point of view, 
there is no reason to consider type 10 and type 12 as separate types, and it 
appears  unnecessary to separate individuals suffering from infections due to 
these two types, for immunity to one probably confers immunity to the other. 
SUMMARY AND CONCLUSION 
1.  In this study a  series of experiments showing the antigenic relationship 
of type 10 and type 12 group A  hemolytic streptococci is reported.  Agglu- 98  GROUP  A  HEI~OLYTIC  STREPTOCOCCI.  III 
tinin, precipitin, and passive protection tests with unabsorbed and reciprocally 
absorbed antisera were employed to show that representative type 10 and 12 
strains contain serologically identical M  antigens but unrelated type-spec~c 
T  antigens. 
2.  Twenty-three other strains of group A hemolytic streptococci previously 
classified as either type 10  or type 12,  collected from various sources,  were 
shown to have an antigenic composition similar to one or the other of the two 
representative type strains. 
3.  The relationship of the two specific antigens, M and T, must be considered 
when any method employing the agglutinin reaction for the typing of group A 
hemolytic streptococci is used. 
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